| abstract |
The present invention provides progesterone-containing pharmaceutical oral dosage forms, pharmaceutical kits, and related methods. In one embodiment, an oral dosage form formulated for continuous administration is provided. Oral dosage forms comprise an amount of progesterone and a pharmaceutically acceptable carrier. The oral dosage form is formulated so that when administered to a non-pregnant woman in the follicular phase, the oral dosage form provides at least 0.20 ng / mL serum progesterone C 24h . [Selection] Figure 4 |